Scenario Projections of Respiratory Syncytial Virus Hospitalizations Averted Due to New Immunizations

C. Hansen(Roskilde University), Cécile Viboud(Fogarty International Center), Samantha J. Bents(National Institutes of Health), Amanda C. Perofsky(Northeastern University), Amanda Adler, Helen Y. Chu(University of Washington), Kaiyuan Sun(National Institutes of Health), Lawrence Lee(Public Health – Seattle & King County), Lea M. Starita(University of Washington), Eric J. Chow(University of Washington)
JAMA Network Open
June 11, 2025
10.1001/jamanetworkopen.2025.14622
Cited by 5

Related Papers

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
|The Lancet Infectious Diseases|2014|965
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
|JAMA|2022|909
Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project
|Journal of Global Health|2019|717
The effects of the COVID-19 pandemic on community respiratory virus activity
|Nature Reviews Microbiology|2022|650